Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology.

Go back to Resources

Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology.

Authors:

Secondary:

Volume:

Pagination:

PMID:

DOI:

Abstract:

Go back to Resources

The integrated National NeuroAIDS Tissue Consortium database: a rich platform for neuroHIV research.

Go back to Resources

The integrated National NeuroAIDS Tissue Consortium database: a rich platform for neuroHIV research.

Authors:

Secondary:

Volume:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.

Go back to Resources

Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Abstract:

Go back to Resources

Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial.

Go back to Resources

Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Abstract:

Go back to Resources

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.

Go back to Resources

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.

Authors:

Secondary:

PMID:

DOI:

Abstract:

Go back to Resources

Air Pollution Exposure Monitoring among Pregnant Women with and without Asthma.

Go back to Resources

Air Pollution Exposure Monitoring among Pregnant Women with and without Asthma.

Authors:

Secondary:

Volume:

Issue:

PMID:

DOI:

Abstract:

Go back to Resources

Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.

Go back to Resources

Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.

Authors:

Secondary:

PMID:

DOI:

Abstract:

Go back to Resources

Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2.

Go back to Resources

Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Abstract:

Go back to Resources

Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.

Go back to Resources

Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Abstract:

Go back to Resources

Validation of the NIDA-modified ASSIST as a Screening Tool for Prenatal Drug Use in an Urban Setting in the United States.

Go back to Resources

Validation of the NIDA-modified ASSIST as a Screening Tool for Prenatal Drug Use in an Urban Setting in the United States.

Authors:

Secondary:

PMID:

DOI:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 90
  • Page 91
  • Page 92
  • Page 93
  • Current page 94
  • Page 95
  • Page 96
  • Page 97
  • Page 98
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions